Edema causes swelling associated with congestive heart failure, cirrhosis of the liver and renal disease
Furosemide tablets are a copycat of the Lasix drug and the Office of Generic Drugs, FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as Lasix.
Furosemide is particularly useful when an agent with greater diuretic potential is desired. Also Furosemide may be used in adults for the treatment of hypertension.
“This approval represents an opportunity for RPI to introduce another affordable generic alternative,” said Jim Meehan, vice president, US Sales and Marketing for RPI. “This approval is the result a strategic alliance with Ipca Laboratories of Mumbai, India, who will develop a number of generic prescription pharmaceutical products which will be marketed by RPI in the US in the future, following US FDA approval,” said Jim Meehan, vice president, US Sales and Marketing for RPI.
Ranbaxy Pharmaceuticals based in Florida, is a wholly owned subsidiary of Ranbaxy Laboratories Limited, India’s largest pharmaceutical company. Ranbaxy Pharmaceuticals concentrates on the sale of generic and branded prescription drugs in the US market.